We expect five earth shaking news (probably in the following order):
1. Partnership: it is just matter of time for a company with data of this magnitude (it should be under a serious talk now -in a finalizing stage)
2. Buy-out: Big pharmas are hungry at a compound that work incredibly well like Zerenex.
3. NDA submission next Q.
4. Pre-dialysis data: Unless a buy-out till this, PPS should go over $20. Pretty sure.
We will have lots of good publicity on the benefits of the drug in between.
There will be talks and news articles dealing with Pre-dialysis which will be big benefit to share price.
Sentiment: Strong Buy
3.5 EMA submission. EU approval would more than double the market for Z.
4.25 Japanese data. Should bolster case for pre-dialysis results
4.5 Japanese approval. Would help alleviate concerns over regulatory approval in US